Advisornet Financial’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-302
Closed -$74K 2532
2022
Q3
$74K Buy
302
+5
+2% +$1.35K 0.01% 736
2022
Q2
$74K Buy
297
+9
+3% +$2.43K 0.01% 764
2022
Q1
$95K Buy
288
+2
+0.7% +$616 0.01% 774
2021
Q4
$103K Buy
+286
New +$96.6K 0.01% 802
2020
Q4
Sell
-68
Closed -$19K 1887
2020
Q3
$19K Hold
68
﹤0.01% 1118
2020
Q2
$16K Hold
68
﹤0.01% 1180
2020
Q1
$10K Hold
68
﹤0.01% 1273
2019
Q4
$12K Buy
68
+56
+467% +$10.4K ﹤0.01% 1354
2019
Q3
$2K Hold
12
﹤0.01% 1707
2019
Q2
$3K Buy
+12
New +$3.18K ﹤0.01% 1488

Other funds holding ABMD

Advisornet Financial's ABMD Position: Q4 2022 in Review

Advisornet Financial sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 302 shares — an estimated $74K sold.

Advisornet Financial first reported a position in ABMD in Q2 2019 and held it in 10 quarters. The position peaked at $103K in Q4 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Advisornet Financial reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Advisornet Financial sold 302 Abiomed Inc shares in Q4 2022, an estimated $74K.
  • Advisornet Financial first reported a position in Abiomed Inc in Q2 2019 and held it in 10 quarters.
  • Advisornet Financial's Abiomed Inc position peaked at $103K in Q4 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Advisornet Financial's 13F filing for Q4 2022, filed 13 Jan 2023.